SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

19 May 2025 Evaluate
A decrease of about -34.55% in the sales to Rs. 244.32 millions was observed for the quarter ended March 2025. The sales stood at Rs. 373.32 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 65.97 millions from Rs. 125.93 millions, a decline of -47.61% on QoQ basis.The company reported a degrowth in operating Profit to 121.63 millions from 182.55 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 244.32 373.32 -34.55 1085.96 1258.95 -13.74 1085.96 1258.95 -13.74
Other Income 22.87 13.24 72.73 37.30 30.71 21.46 37.30 30.71 21.46
PBIDT 121.63 182.55 -33.37 429.42 448.77 -4.31 429.42 448.77 -4.31
Interest 9.58 1.46 556.16 20.77 5.98 247.32 20.77 5.98 247.32
PBDT 112.05 181.09 -38.12 408.65 442.79 -7.71 408.65 442.79 -7.71
Depreciation 24.24 18.57 30.53 95.67 61.10 56.58 95.67 61.10 56.58
PBT 87.81 162.52 -45.97 312.98 381.69 -18.00 312.98 381.69 -18.00
TAX 21.84 36.59 -40.31 81.99 100.52 -18.43 81.99 100.52 -18.43
Deferred Tax -0.81 -0.15 440.00 -0.45 6.74 -106.68 -0.45 6.74 -106.68
PAT 65.97 125.93 -47.61 230.99 281.17 -17.85 230.99 281.17 -17.85
Equity 128.38 125.83 2.03 128.38 125.83 2.03 128.38 125.83 2.03
PBIDTM(%) 49.78 48.90 1.81 39.54 35.65 10.93 39.54 35.65 10.93

Shree Ganesh Remed. Share Price

472.90 -13.75 (-2.83%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×